Gas Chromatography
Gas Chromatography
1 2 3 4
Vinod D. Usnale* Rohit D. Usnale , Pooja P. Dahale , Vijay R. Chakote
Corresponding author
Vinod D. Usnale1
Department of Pharmaceutics
INTRODUCTION:
Calibration and qualification of equipment are key requirements in GMP guidelines
(EU GMP Guide, Annex 15 to EU GMP Guide, and FDA’s Code of Federal Regulations, 21
CFR Part 211). These requirements also apply to instruments and systems in analytical
laboratories of the pharmaceutical industry. Besides calibration and qualification, the
validation of computerised systems is another key issue. The software components associated
with the instruments and systems must be shown to be fit for their intended purpose.
Computer validation requirements and guidances for the pharmaceutical industry are laid
down, amongst others, by the EU (Annex 11 to EU GMP Guide, the PIC/S (Good Practices
for Computerised Systems in Regulated “GXP” Environments”), GAMP® (Good Automated
Manufacturing Practice), and FDA’s Part 11.
The United States Pharmacopoeia (USP) has adopted ,Analytical Instrument Qualification,
in 2008. This General Chapter has been updated in 2017 and a new version is coming up
soon.
The pharmaceutical industry relies on the precision and accuracy of analytical instruments to
obtain valid data for research, development, manufacturing, and quality control. Indeed,
advancements in the automation, precision, and accuracy of these instruments parallel those
of the industry itself. Through published regulations, regulatory agencies require
pharmaceutical companies to establish procedures assuring that the users of analytical
instruments are trained to perform their assigned tasks. The regulations also require the
companies to establish procedures assuring that the instruments that generate data supporting
regulated product testing are fit for use. The regulations, however, do not provide clear and
authoritative guidance for validation/qualification of analytical instruments.
• Review and propose an effective and efficient instrument validation process that focuses on
outcomes, and not only on generating documentation.
• Define the roles and responsibilities of those associated with an instrument's validation.
• Publish a white paper on analytical instrument validation that may aid in the development of
formal future guidelines, and submit it to regulatory agencies.
The various parties agreed that processes are "validated" and instruments are "qualified."
This document, therefore, will use the phrase "Analytical Instrument Qualification (AIQ)," in
lieu of "Analytical Instrument Validation." The term "validation" should henceforth be
reserved for processes that include analytical procedures and software development.
DEFINATION OF QUALIFICATION:
Qualification is defined as an action of providing that equipment or ancillary systems
are properly installed, work correctly, and actually lead to the expected results.
Qualification is part of validation, but the individual qualification steps alone do not
constitute process validation.
It is the entire process by which products are obtained from manufacturers or distributors,
examined and tested, and then identified as a qualified products list.
Analytical instrument qualification helps justify the continued use of equipment, but it alone
does not ensure the quality of data. Analytical instrument qualification is 1 of the 4 critical
components of data quality. Figure 1 shows these components as layered activities within a
Quality Triangle. Each layer adds to the overall quality. Analytical Instrument Qualification
forms the base for generating quality data. The other essential components for generating
quality data are the following: Analytical Methods Validation, System Suitability Tests, and
Quality Control Checks.
Analytical methods validation is documented evidence that an analytical method does what it
purports to do and delivers the required attributes. Use of a validated method should instill
confidence that the method can generate test data of acceptable quality.
Various user groups and regulatory agencies have defined procedures for method validation.
Specific requirements regarding methods validations appear in many references on the
subject. Among some common parameters generally obtained during method validations are
the following:
• precision.
• sensitivity
• specificity
• repeatability
• linearity
• analyte
Most analyses are performed using reference or calibration standards. Single- or multipoint
calibration or standardization correlates instrument response with a known analyte quantity or
quality. Calibrators/standards are generally prepared from certified materials suitable for the
test. Besides calibration or standardization, some analyses also require the inclusion of
quality control check samples, which provide an in-process assurance of the test’s
performance suitability.
In summary, AIQ and analytical method validation assure the quality of analysis before
conducting the tests. System suitability tests and quality control checks assure the high
quality of analytical results immediately before or during sample analysis.
Qualification phases:
Qualification of instruments is not a single, continuous process but instead results
from many discrete activities. For convenience, these activities have been grouped into 4
phases of qualification.
Design qualification:
The AIQ process timeline begins with the DQ phase at the vendor’s site, in which the
instrument is developed, designed, and produced in a validated environment according to
good laboratory practices (GLP), current good manufacturing practices (CGMP), and ISO
9000 standards. Users should ensure that the instrument is fit for their intended use and that
the manufacturer has adopted a quality system for development, manufacturing, and testing
and has adequate support for installation, service, and training. Vendor supplied
documentation and consumer audits of the vendor are usually sufficient to satisfy users’ DQ
requirements. Design qualifications are the specifications a manufacturer uses to describe a
device or equipment. It seeks to demonstrate that the requirements detailed in the User
Requirements Specifications (URS) are all going to be executed satisfactorily before a new
design can be authorized.
Since the instrument design is already in place for the commercial off-the-shelf (COTS)
systems, the user does not need to repeat all aspects of DQ. However, users should ensure
that COTS instruments are suitable for their intended applications and that the manufacturer
has adopted a quality system for developing, manufacturing, and testing.
Installation Qualification:
Qualification is a documented collection of activities needed to install an instrument in the
user’s environment.
Network and Data Storage: Some analytical systems require users to provide network
connections and data storage capabilities at the installation site. If this is the case, connect the
instrument to the net-work and check its functionality.
Assembly and Installation: Assemble and install the instrument and perform any initial
diagnostics and testing. Assembly and installation of a complex instrument are best done by
the vendor or specialized engineers, whereas users can assemble and in-stall simple ones. For
complex instruments, vendor-established installation tests and guides provide a valuable
baseline reference for determining instrument acceptance.
Installation Verification: Perform the initial diagnostics and testing of the instrument after
installation. On obtaining acceptable results, the user and (when present) the installing
engineer should con-firm that the installation was successful before proceeding with the next
qualification phase.
Fixed Parameters: These tests measure the instrument's non changing, fixed parameters
such as length, height, weight, etc. If the vendor-supplied specifications for these parameters
satisfy the user, he or she may waive the test requirement. However, if the user wants to
confirm the parameters, testing can be performed at the user’s site. Fixed parameters do not
change over the life of the instrument and therefore never need re determining.
Secure Data Storage, Backup, and Archive: When required, secure data handling, such as
storage, backup, and archiving should be tested at the user site according to written
procedures.
Instrument Functions Tests: Test important instrument functions to verify that the
instrument operates as intended by the manufacturer and required by the user. The user
should select important instrument parameters for testing according to the instrument's
intended use. Vendor supplied information is useful in identifying specifications for these
parameters. Tests should be designed to evaluate the identified parameters. Users, or their
qualified designees, should perform these tests to verify that the instrument meets vendor and
user specifications.
The extent of OQ testing that an instrument undergoes depends on its intended applications.
We therefore offer no specific OQ tests for any instrument or application. Nevertheless, as a
guide to the type of tests possible during OQ, consider these, which apply to a high
performance liquid chromatography (HPLC) unit:
• gradient linearity
• detector linearity
Preventive Maintenance and Repairs: When PQ tests fail to meet specifications, the
instrument requires maintenance or repair. For many instruments a periodic preventive
maintenance may also be recommended. Relevant PQ test should be repeated after the needed
maintenance or repair to ensure that the instrument remains qualified.
Instrument Categories:
Modern laboratories typically include a suite of tools. These vary from simple spatulas to
complex automated instruments.
Group A Instruments
Group B Instruments
Group C Instruments
Conformance of Group C instruments to user requirements is highly method specific, and the
conformity bounds are determined by their application. Examples are as follows:
QUALIFICATION OF GC EQUIPMENT
Introduction
The present document is the second Annex of the core document “Qualification of
Equipment”, and it should be used in combination with it when planning, performing and
documenting the GC equipment qualification process.
The core document contains the general introduction and the Level I and II of
qualification, common to all type of instruments, and the present annex contains GC
instrument-related recommendations on parameters to be checked and the corresponding
typical acceptance limits, as well as practical examples on the methodology that can be
used to carry out these checks.
The tests proposed in the Level III and IV of qualification are based on an overall
approach, in which several parameters are checked at the same time in a combined test
procedure, to obtain information on the overall system performance (e.g. peak area
precision, retention time precision, temperature program reproducibility etc).
Nevertheless, it should be noted that it is also acceptable to check these parameters
individually by using other well defined procedure.
LEVEL I
Selection Of Instruments & Suppliers
Level II
Equipment Qualification:
It is recommended to check all requirements set during the selection of the instrument,
and calibration should be performed before putting into service by an accredited external
service supplier, or Internally by appropriately qualified personnel, using certified reference
buffers according to an approved procedure.
Level III
Periodic and motivated instrument
1.Inlet System 1.1 Injector leak test Pressure drop <kPa within 5
minutes covered by overall
1.2 Pressure Flow accuracy test 1
and stability
1.3 Repeatability of
Injection ( overall test 1)
Practical examples of tests and their associated tolerance limits for several parameters related
to the performance of the different modules of a GC are presented below.
These examples can be considered by the OMCLs as possible approaches to perform the
Level III of the equipment qualification process: “Periodic and motivated instrument checks”.
Several tests are proposed to check various parameters at the same time (overall tests).
In order to run the tests in a more economical way, other suitable solutions can be used, as for
example, the “Grob Test” mixture, available from different suppliers (e.g. Alltech, Sigma,
Thames Restek).
1. INLET SYSTEM
The following tests are proposed for the periodic and motivated check of the GC Inlet
System.
Method:
If not otherwise specified by the instrument manufacturer, the leak test is carried out
according to the procedure laid down in the instrument manual or by the built in automatic
leak check procedure of the instrument.
Disconnect the column from the injector and close the injector outlet with a sealed cap.
Close the septum purge and the bypass.
Adjust the flow and pressure controller to the maximal possible value of the pressure
gauge.
Limits:
A direct measurement of these parameters was not deemed practical or necessary, but the
optimal conditions of flow/pressure can be verified by the overall test 1.
Due to the fact that the temperature cannot be reliably measured without opening and
modifying the system and due to the difficulties of introducing a probe inside this module, the
verification of this parameter is considered to be covered by the overall test 2.
After having injected the solutions for the linearity test of the FID detector, in increasing
order, inject the blank and measure the peaks that correspond to the major peaks (= analytes)
in the linearity solutions.
2. OVEN
2.1. REPEATABILITY OF THE OVEN TEMPERATURE CHARACTERISTICS
Due to the fact that the temperature cannot be reliably measured without opening and
modifying the system conditions and that even when introducing a probe inside the oven, its
location would not reflect the real temperature conditions at all points, the verification of this
parameter is covered by the overall tests 2A and 2B.
3. FID DETECTOR
The following tests are proposed for the periodic and motivated check of the GC FID
detector.
Increasing amounts of analyte are injected and a linear response should be obtained. The
verification of this parameter is covered by the overall test 3.
The proper and reproducible functioning of the FID can be demonstrated by checking the
peak areas obtained from a predefined standard solution.
If the instrument has a built-in automatic system for the verification of the noise and drift,
follow the manufacturer’s instructions and apply the defined acceptance criteria.
Settings:
• Column installed
• Suitable flow, depending on column length/diameter
• No injection
• Oven temperature: 40°C
• Detector on and heated at working temperature (270- 300°C)
Method:
Limits:
The acceptance criteria for these parameters have to be chosen in accordance with the
instrument vendor’s instructions and the intended use of the instrument.
If no instructions are given, the user has to pre-define these acceptance criteria by
taking into account the previous experience and the intended use of the instrument.
No fixed values can be pre-defined in this guideline due to the high variety of
integration systems used and consequently the acceptance criteria may be expressed
in different units (voltage, current, arbitrary units per time).
OVERALL TEST 1
The overall test 1 covers the following parameters:
- In split mode
Settings:
• Carrier gas: He
• Velocity: 25cm/sec
• Split: 1:100
• Injection: 1µl
• Injector temperature: 220°C
• Oven temperature: 100°C isotherm
• Detector temperature: 300°C
• Runtime: 8 min
• Retention time of 1-octanol: about 5 min
Method:
Carry out 6 consecutive injections of the test solution and calculate the RSD of the different
peak areas and retention times.
Limits:
Retention time repeatability: the RSD of the retention times should be ≤ 2.0%.
Peak area precision (split and split less mode): the RSD of the peak areas should be ≤ 3.0%
OVERALL TEST 2
The overall test 2 covers the following parameters:
-Injector, oven and detector temperature accuracy and stability, retention time repeatability -
Two alternative tests are proposed
1.Overall test 2
A Test solution:
0.035 ml 1-octanol
0.035 ml 2-octanone
0.035 ml 2,6-dimethylanilin
0.035 ml n-tridecane
0.035 ml n-tetradecane
35 mg n-eicosane
Dissolved in 50 ml Dichloromethane
Settings:
Method:
Inject the solution twice and calculate the relative retention times in relation to n-eicosane
(RRT = 1)
Limits:
The RSD of each RRT from two consecutive injections should be ≤ 1.0%2.Overall test 2B
Test Solution:
Settings:
• Solvent: Tetradecane
• Oven temperature: 110°C
• Gradient programme: 110°C, 20°C/min, 180°C (final time: 3.5 min)
• Detector temperature: 250°C
• Injector temperature: 200°C
• Detector: FID
• Flow rates: Carrier gas (Helium): 2 ± 0.2 ml/min Hydrogen: 30 ± 1.0 ml/min
• Air: 400 ± 20.0 ml/min
• Makeup (Nitrogen): 28 ± 1.0 ml/min
• Split ratio: 15
• Split vent: 30 ± 3.0 ml/min
• Septum purge: 3-5 ml/min
Method:
• Injection sequence:
1) Blank (Tetradecane)
2) 6 replicates of the test solution. Calculate the mean of the retention times and peak areas
and the relative standard deviation of n-Nonane and n-Hexadecane
Limits:
• Retention time repeatability: RSD of the peak retention times of the 6 replicates ≤ 2%
• Retention time (Rt) accuracy; Nevertheless, individual ranges should be predefined by
the laboratory depending on the column used (e.g. Rt ± 0.2 min).
OVERALL TEST 3
This test is a modified version of the overall test 1 to be used for the verification of:
It is described for both split and split less mode and may be combined with overall test 1.
Split mode:
Settings:
Injection sequence:
• 5.0 ml of the test solution diluted to 25.0 ml with n-hexane (2 µl/ml): 2 injections
• 10.0 ml of the test solution diluted to 25.0 ml with nhexane (4 µl/ml): 2 injections
• 15.0 ml of the test solution diluted to 25.0 ml with n-hexane (6 µl/ml): 2 injections
• 20.0 ml of the test solution diluted to 25.0 ml with n-hexane (8 µl/ml): 2 injections
• If combined with overall test 1 for repeatability: test solution (10 µl/ml): 6 injections
n-hexane as blank (carry over)
Settings:
Injection sequence:
• 5.0 ml of the test solution diluted to 25.0 ml with n-hexane (0.2 µl/ml): 2 injections
• 10.0 ml of the test solution diluted to 25.0 ml with n-hexane (0.4 µl/ml): 2 injections
• 15.0 ml of the test solution diluted to 25.0 ml with n-hexane (0.6 µl/ml): 2 injections
• 20.0 ml of the test solution diluted to 25.0 ml with n-hexane (0.8 µl/ml): 2 injections
If combined with overall test 1 for repeatability: test solution (1 µl/ml): 6 injections n-hexane
as blank (carry over)
Limits:
• Linearity: coefficient of correlation of the calibration line obtained with the reference
solutions and the test solution: r 2 ≥ 0.999.
• Carry-over: the percentage of the peak area corresponding to the analyte in the blank
solution should be ≤ 0.2% of the peak area of this analyte in the chromatogram
obtained with the solution with the highest concentration within the sequence.
Level IV.
In-use instrument checks Examples of requirements for GC instruments with FID.
• It is used to study thermal transitions of a polymer/sample (the changes that take place on
heating)
– For example:
• The crystallization
Principle
• The sample and reference are maintained at the same temperature, even during a thermal
event in the sample
• The energy required to maintain zero temperature difference between the sample and the
reference is measured
• During a thermal event in the sample, the system will transfer heat to or from the sample
pan to maintain the same temperature in reference and sample pans.
There are two pans, In sample pan, polymer is added, while the other, reference pan is left
empty
• The computer turns on heaters, and let them heat the two pans at a specific rate, usually
10oC/min.
• The computer makes absolutely sure that the heating rate stays exactly the same throughout
the experiment.
Sample holder
Sensors
Furnace
Temperature controller
• Supply the differential thermal power to the heaters to maintain the temperature of the
sample and reference at the program value
• Sample and reference holders are connected by a low-resistance heat flow path
Sensors
• Chromel® (an alloy made of 90% nickel and 10% chromium)-constantan area
thermocouples (differential heat flow)
Furnace
Temperature controller
• The temperature difference between the sample and reference is converted to differential
thermal power, which is supplied to the heaters to maintain the temperature of the sample and
reference at the program value.
INSTALLATION QUALIFICATION
IN
• A clean environment.
ON
Near
• A power outlet (120 Vac, 50 or 60 Hz, 15amps). A step up/down line transformer may
be required if the unit is operated from a higher or lower line voltage.
• Your controller.
• A compressed lab air and purge gas supply for use during cooling, sub ambient, and
high temperature experiments.
Away from
• Dusty environments.
• Exposure to direct sunlight.
• Direct air drafts (fans, room air ducts).
• Poorly ventilated areas.
• Flammable materials
PERFORMANCE QUALIFICATION
The most common procedure is to run an indium standard under the normal test conditions
and measure the heat of fusion value and melting onset temperature.
• These values are then compared with literature values and a check made against accepted
limits.
+0.5 ◦C for temperature or 1% for heat of fusion may be accepted, though tighter
limits of •+0.3 ◦C and 0.1% may also be adopted.
The choice of limits depends on how accurate you need to be.
Indium is the easiest standard to use because of its stability and relatively low melting
point of 156.6 ◦C, which means it can often be reused, provided it is not heated above
180◦C.
SUMMARY;
The purpose of the use of analytical instruments is to generate reliable data.
Instrument qualification helps fulfill this purpose. No authoritative guide exists that considers
the risk of instrument failure and combines that risk with users’ scientific knowledge and
ability to use the instrument to deliver reliable and consistent data. In the absence of such a
guide, the qualification of analytical instruments has become a subjective and often fruitless
document-generating exercise. Taking its cue from the new FDA initiative, "Pharmaceutical
GMP’s for the 21st Century," an efficient, science- and risk-based process for AIQ was
discussed at a workshop on analytical instrument qualification. This report represents the
distillate of deliberations on the complicated issues associated with the various stages of
analytical instrument qualification. It emphasizes AIQ’s place in the overall process of
obtaining quality reliable data from analytical instruments and offers an efficient process for
its performance, one that focuses on scientific value rather than on producing documents.
Implementing such a process should remove ambiguous interpretations by various groups.
Data quality is built on the foundation of method and software validation, AIQ, and system
suitability. Each of these components plays a significant role in the process of validation. In a
regulated laboratory, instruments must produce reliable data, and only a proper AIQ process
can fulfill this mission. During all phases of clinical development, including the use of small
scale facilities or laboratories to manufacture batches of APIs for use in clinical trials,
procedures should be in place to ensure that equipment is calibrated, clean and suitable for its
intended use. Procedures for the use of facilities should ensure that materials are handled in a
manner that minimizes the risk of contamination and cross-contamination. So validation and
calibration is very important for analytical instruments.
REFERENCES
1. Laboratory Controls, General Requirements, Code of Federal Regulations, Part
211.160, Title 21, Rev. April 2000.
2. Maintenance and Calibration of Equipment, Code of Federal Regulations, Part 58.63,
Title 21, Rev. April 2000.
3. Cloud PA. Validating a Laboratory Incubator, BioPharm 10 (11), 30–42, 1997.
4. Bedson P., The Development and Application of Guidance on Equipment
Qualification of Analytical Instruments, Accred. Qual. Assur. 1 (6), 265–274, 1996.
5. Anjaneyulu Y, Marayya R, Quality Assurance and Quality Management in
Pharmaceutical industry, Pharmabook Syndicate, 2005.
6. International Conference on Harmonization, Harmonized Tripartite Guideline,
Validation of Analytical Procedures, Text and Methodology, Q2(R1), Nov. 2005.
7. International Conference on Harmonization. ICH Q2B: Validation of Analytical
Procedures: Methodology. Federal Register. 1997; 62 FR 27463.
http://www.fda.gov/cder/guidance/1320fnl.pdf.
8. US Food and Drug Administration. General Principles of Software Validation. Final
Guidance for Industry and FDA Staff. Rockville, MD: US Department of Health and
Human Services, Food and Drug Admini-stration, January, 2002.
9. US Food and Drug Admnistration. Guidance for Industry: Bioanalytical Method
Validation. US Dept of Health and Human Services, Food and Drug Administration;
May, 2001.
10. Shah VP, Midha KM, Findlay JWA, et al. Workshop/Conference Report:
Bioanalytical Method Validation: A Revisit with a Decade of Progress. Pharm Res.
2000;17:1551-1557.
11. International Conference on Harmonization. ICH Q2A: Text on Validation of
Analytical Procedures. Federal Register. 1995;60 FR 11260.
http://www.fda.gov/cder/guidance/ichq2a.pdf.
12. International Conference on Harmonization. ICH Q2B: Validation of Analytical
Procedures: Methodology. Federal Register. 1997;62 FR 27463.
http://www.fda.gov/cder/guidance/1320fnl.pdf.
13. US Department of Health and Human Services. Draft Guidance for Industry:
Analytical Procedures and Methods Validation, Chemistry, Manufacturing and
Controls Documentation. Rockville, MD: US Dept of Health and Human Services,
Food and Drug Administration. Aug 2000.
http://www.fda.gov/cder/guidance/2396dft.pdf.
14. United States Pharmacopoeial Convention. United States Pharmacopoeia 26, National
Formulary 21, Validation of Compendial Methods. Rockville, MD: United States
Pharmacopoeial Convention; 2003.